Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Jul 18, 2025, 4:00 PM
1.700
+0.030 (1.79%)
After-hours: Jul 18, 2025, 7:50 PM EDT
Cabaletta Bio Stock Forecast
CABA's stock price has decreased by -77.91% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts that cover Cabaletta Bio stock have a consensus rating of "Strong Buy" and an average price target of $14.43, which forecasts a 764.07% increase in the stock price over the next year. The lowest target is $3 and the highest is $25.
Price Target: $14.43 (+764.07%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 11, 2025.
Analyst Ratings
The average analyst rating for Cabaletta Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 4 |
| Buy | 2 | 2 | 3 | 2 | 2 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 10 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,397.01% | Jun 11, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $17 → $13 | Strong Buy | Maintains | $17 → $13 | +678.44% | May 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $23 → $25 | Strong Buy | Maintains | $23 → $25 | +1,397.01% | May 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $23 → $25 | Strong Buy | Maintains | $23 → $25 | +1,397.01% | May 15, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $3 | Hold | Maintains | $6 → $3 | +79.64% | Apr 1, 2025 |
Financial Forecast
Revenue This Year
n/a
from 329.92M
Revenue Next Year
n/a
EPS This Year
-2.46
from -2.36
EPS Next Year
-2.30
from -2.46
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.8M | 21.0M | 26.3M | ||
| Avg | 5.1M | 2.9M | 3.8M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -88.9% | 311.8% | 800.8% | ||
| Avg | -98.5% | -42.9% | 31.2% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.45 | -1.00 | -0.92 | ||
| Avg | -2.46 | -2.30 | -2.14 | ||
| Low | -3.13 | -3.08 | -2.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.